characteristics.text: SAMN22725505
characteristics.characteristic: External Id
characteristics.text: NCI/NIH
characteristics.characteristic: INSDC center name
characteristics.text: 2022-05-26T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-05-26T03:08:19.313Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS10766644
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS10766644
characteristics.characteristic: SRA accession
characteristics.text: HT-29-derived clone 596-1 cell
characteristics.characteristic: cell type
characteristics.text: ephrinB2 silencing
characteristics.characteristic: genotype
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: HT-29 colon adenocarcinoma
characteristics.characteristic: source_name
characteristics.text: Clone 596-1 NovaSeq Replicate 2 Dox
characteristics.characteristic: title
characteristics.text: Doxycycline treated
characteristics.characteristic: treatment